Showing results (51-60 of 181) with videos related to
Sort By:
Pageof 19
Clinical Immunology (Orlando, Fla.)|May 6, 2008
Recurrence of autoreactive antigen-specific CD4+ T cells in autoimmune diabetes after pancreas transplantationElsa Laughlin, George Burke, Alberto Pugliese, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 16, 2019
CD25 and Protein Phosphatase 2A Cooperate to Enhance IL-2R Signaling in Human Regulatory T CellsYing Ding, Aixin Yu, George C Tsokos, et al.The Journal of Experimental Medicine|March 9, 2005
Essential role for interleukin-2 for CD4(+)CD25(+) T regulatory cell development during the neonatal periodAllison L Bayer, Aixin Yu, Dennis Adeegbe, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 15, 2013
IL-2R signaling is essential for functional maturation of regulatory T cells during thymic developmentGuoyan Cheng, Aixin Yu, Michael J Dee, et al.Immunity|February 3, 2009
A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cellsAixin Yu, Linjian Zhu, Norman H Altman, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 11, 2011
The basis of distinctive IL-2- and IL-15-dependent signaling: weak CD122-dependent signaling favors CD8+ T central-memory cell survival but not T effector-memory cell developmentIris Castro, Aixin Yu, Michael J Dee, et al.Nature Reviews. Immunology|February 26, 2022
Engineering IL-2 for immunotherapy of autoimmunity and cancerRosmely Hernandez, Janika Põder, Kathryn M LaPorte, et al.Diabetes|December 5, 2020
Baseline Assessment of Circulating MicroRNAs Near Diagnosis of Type 1 Diabetes Predicts Future Stimulated Insulin SecretionIsaac Snowhite, Ricardo Pastori, Jay Sosenko, et al.The Journal of Clinical Endocrinology and Metabolism|January 28, 2025
Insulitis and exocrinitis in autoantibody-positive non-diabetic individuals: role of HLA genotypesMarc Diedisheim, Roberto Mallone, Alberto Pugliese, et al.Journal for Immunotherapy of Cancer|June 3, 2023
Robust IL-2-dependent antitumor immunotherapy requires targeting the high-affinity IL-2R on tumor-specific CD8Kathryn M LaPorte, Rosmely Hernandez, Alicia Santos Savio, et al.Pageof 19